[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application

Clinical trial NCT05458544 · UNKNOWN

Trial details

NCT number: NCT05458544
Sponsor: FutureChem
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer

Start date: 2022-09-01
Primary completion: 2025-06-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.